BEIJING -- China's Sinovac Biotech is prepared to rapidly increase output of its coronavirus vaccine candidate in response to demand overseas, the head of the pharmaceutical maker said Thursday,
Sinovac just completed a plant in Beijing in July capable of producing 300 million doses of a vaccine yearly. Construction took roughly four months. The company opened the plant to foreign media for the first time Thursday.
